Recombinant factor VIIa - new treatment option for control of intractable bleeding in surgical and trauma patients and in other haemostasis disorders

URN:NBN:SI:DOC-KZHY4NFX2004Andoljšek, DušanZver, Samodocuments/doc/K/URN_NBN_SI_doc-KZHY4NFX_001.pdfdocuments/doc/K/URN_NBN_SI_doc-KZHY4NFX_001.txtarticlestr. I-115-I-1211318-034717682649URN:NBN:SI:doc-KZHY4NFXslvSlovensko zdravniško društvoZdravniški vestnikBY-NCAnticoagulantsAntikoagulansiBlood Platelet DisordersDiseminirana, intravaskularna koagulacijaDisseminated Intravascular CoagulationFactor VIIaFaktor VIIaHemodilucijaHemodilutionHemophiliaHemorrhageHemostasis, SurgicalHemostaza kirurškaKrvavitevRane in poškodbeRecombinant ProteinsRekombinantne beljakovineTherapeutic UseThrombocytopeniaTrombociti, motnjeTrombocitopenijaWounds And InjuriesRecombinant factor VIIa - new treatment option for control of intractable bleeding in surgical and trauma patients and in other haemostasis disordersRekombinantni faktor VIIa - nova možnost obvladovanja neobvladljive krvavitve pri kirurških bolnikih, poškodovancih in drugih motnjah hemostaze